Can Aidi injection restore cellular immunity and improve clinical efficacy in non-small-cell lung cancer patients treated with platinum-based chemotherapy? A meta-analysis of 17 randomized controlled trials following the PRISMA guidelines

BACKGROUND: Aidi injection is an adjuvant chemotherapy drug commonly used in China. Can Aidi injection restore the cellular immunity and improve the clinical efficacy in non-small-cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy? There is a lack of strong evidence to prove...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Zheng, Wang, Chengqiong, Sun, Yongping, Li, Nana, Li, Jing, Chen, Ling, Yao, Xingsheng, Ding, Jie, Ma, Hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591112/
https://www.ncbi.nlm.nih.gov/pubmed/27858864
http://dx.doi.org/10.1097/MD.0000000000005210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591112/
https://www.ncbi.nlm.nih.gov/pubmed/27858864
http://dx.doi.org/10.1097/MD.0000000000005210

Ejemplares similares